Quest Diagnostics’ ClariSure™ array CGH postnatal test was approved for patient testing in New York in March 2009.

Array CGH describes a technology in which microarrays comprised of well-defined DNA probes are used to screen DNA test samples to detect changes in sequence copy number.

Microarray-based comparative genomic hybridization (array CGH) testing has been shown to be efficacious in the diagnostic setting and is being rapidly incorporated as an adjunct to traditional ...

Test evaluation was further hampered by the lack of an available genotypic reference standard for array CGH that could independently verify the “truth” in all subjects, especially in those ...

They recommended that advanced genomic technologies, such as array CGH, be broadly deployed by cell culture banks to ensure consistency of the cells they provide to the research community.

Moreover, when CNVs are suspected, custom array CGH can detect the exact range of CNVs. These genetic analysis tools have enabled us to diagnose almost all inherited kidney diseases. In this lecture, ...

Microarray based comparative genomic hybridisation (array CGH) is a new technology with uses developing in various diagnostic areas within the NHS. One important context is the investigation of ...

Two clinical scenarios are presented in the health economic evaluation: one where the exome virtual gene panel test is offered in addition to standard genetics tests and another in which it is offered ...